PANoptosis opens new treatment options for allergic bronchopulmonary aspergillosis

Background: Allergic bronchopulmonary aspergillosis (ABPA) is a rare airway disorder primarily affecting patients with asthma and cystic fibrosis. Persistent airway inflammation brought on by Aspergillus fumigatus exacerbates the underlying condition and can cause significant respiratory damage. Tre...

Full description

Saved in:
Bibliographic Details
Main Authors: Dalan Smallwood, MD, Richard F. Lockey, MD, Narasaiah Kolliputi, PhD
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772829324000948
Tags: Add Tag
No Tags, Be the first to tag this record!